Takeda Pharmaceutical (TAK) Earnings Date, Estimates & Call Transcripts $14.98 +0.12 (+0.77%) Closing price 03:59 PM EasternExtended Trading$14.98 0.00 (0.00%) As of 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Takeda Pharmaceutical Earnings Summary Takeda Pharmaceutical released Q1 2026 earnings on July 30, 2025, reporting an EPS of $0.52, which beat analysts' consensus estimates of $0.47 by $0.05. Quarterly revenue was reported to be $7.45 billion, below analyst estimates of $7.96 billion. With a trailing EPS of $0.30 and a P/E Ratio of 49.92, Takeda Pharmaceutical's earnings are expected to grow 0.61% next year, from $1.64 to $1.65 per share. Upcoming Q2 Earnings DateOct. 30Before Market OpensEstimatedConsensus EPS (Jul. 30) $0.47 Actual EPS (Jul. 30) $0.52 Beat By $0.05 Actual Revenue (Jul. 30) $7.45BQ1 2026 Earnings ResourcesQ1 2026 Earnings ReportConference Call Transcript & Audio Interim Report Slide DeckTAK Upcoming EarningsTakeda Pharmaceutical's next earnings date is estimated for Thursday, October 30, 2025, based on past reporting schedules. Slide DeckFull Screen Slide DeckPowered by Get Takeda Pharmaceutical Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Takeda Pharmaceutical and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataTAK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TAK Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Takeda Pharmaceutical Analyst EPS EstimatesCurrent Year EPS Consensus Estimate $1.64 EPSNext Year EPS Consensus Estimate $1.65 EPS Takeda Pharmaceutical Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 10/30/2025(Estimated)--------7/30/2025Q1 2026$0.47$0.52+$0.05$0.27$7.96B$7.45B5/8/2025Q4 2025$0.24$0.16 -$0.08-$0.21$8.02B$7.34B1/30/2025Q3 2025$0.34$0.42+$0.08$0.05--7/31/2024Q1 2025$0.37$0.56+$0.19$0.93-$7.75B2/1/2024Q3 2024-$0.51-$0.79-$7.52B10/26/2023Q2 2024-$0.50-$0.86-$6.94B Takeda Pharmaceutical Earnings - Frequently Asked Questions When is Takeda Pharmaceutical's earnings date? Takeda Pharmaceutical has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 30th, 2025 based off last year's report dates. Learn more on TAK's earnings history. What guidance has Takeda Pharmaceutical issued on next quarter's earnings? Takeda Pharmaceutical updated its FY 2025 earnings guidance on Wednesday, July, 30th. The company provided earnings per share guidance of 3.360-3.360 for the period. The company issued revenue guidance of $31.3 billion-$31.3 billion. Did Takeda Pharmaceutical beat their earnings estimates last quarter? In the previous quarter, Takeda Pharmaceutical (NYSE:TAK) reported $0.52 earnings per share (EPS) to beat the analysts' consensus estimate of $0.47 by $0.05. Learn more on analysts' earnings estimate vs. TAK's actual earnings. How can I listen to Takeda Pharmaceutical's earnings conference call? The conference call for Takeda Pharmaceutical's latest earnings report can be listened to online. Listen to Conference Call How can I read Takeda Pharmaceutical's conference call transcript? The conference call transcript for Takeda Pharmaceutical's latest earnings report can be read online. Read Transcript How much revenue does Takeda Pharmaceutical generate each year? Takeda Pharmaceutical (NYSE:TAK) has a recorded annual revenue of $4.48 trillion. How much profit does Takeda Pharmaceutical generate each year? Takeda Pharmaceutical (NYSE:TAK) has a recorded net income of $712.33 million. TAK has generated $0.30 earnings per share over the last four quarters. What is Takeda Pharmaceutical's price-to-earnings ratio? Takeda Pharmaceutical (NYSE:TAK) has a trailing price-to-earnings ratio of 49.92 and a forward price-to-earnings ratio of 9.13. What is Takeda Pharmaceutical's EPS forecast for next year? Takeda Pharmaceutical's earnings are expected to grow from $1.64 per share to $1.65 per share in the next year, which is a 0.61% increase. More Earnings Resources from MarketBeat Related Companies Sanofi Earnings Results GSK Earnings Results argenex Earnings Results BeOne Medicines Earnings Results Insmed Earnings Results BioNTech Earnings Results Teva Pharmaceutical Industries Earnings Results Summit Therapeutics Earnings Results Genmab A/S Earnings Results Viatris Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost Pressures This page (NYSE:TAK) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Takeda Pharmaceutical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Takeda Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access